{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:45:13Z","timestamp":1790693113124,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Optical genome mapping (OGM) is a new genome-wide technology that can reveal both structural genomic variations (SVs) and copy number variations (CNVs) in a single assay. OGM was initially employed to perform genome assembly and genome research, but it is now more widely used to study chromosome aberrations in genetic disorders and in human cancer. One of the most useful OGM applications is in hematological malignancies, where chromosomal rearrangements are frequent and conventional cytogenetic analysis alone is insufficient, necessitating further confirmation using ancillary techniques such as fluorescence in situ hybridization, chromosomal microarrays, or multiple ligation-dependent probe amplification. The first studies tested OGM efficiency and sensitivity for SV and CNV detection, comparing heterogeneous groups of lymphoid and myeloid hematological sample data with those obtained using standard cytogenetic diagnostic tests. Most of the work based on this innovative technology was focused on myelodysplastic syndromes (MDSs), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL), whereas little attention was paid to chronic lymphocytic leukemia (CLL) or multiple myeloma (MM), and none was paid to lymphomas. The studies showed that OGM can now be considered as a highly reliable method, concordant with standard cytogenetic techniques but able to detect novel clinically significant SVs, thus allowing better patient classification, prognostic stratification, and therapeutic choices in hematological malignancies.<\/jats:p>","DOI":"10.3390\/diagnostics13111841","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T01:36:28Z","timestamp":1684978588000},"page":"1841","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA"],"prefix":"10.3390","volume":"13","author":[{"given":"Nicoletta","family":"Coccaro","sequence":"first","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-724X","authenticated-orcid":false,"given":"Luisa","family":"Anelli","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Zagaria","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3323-6445","authenticated-orcid":false,"given":"Francesco","family":"Tarantini","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2509-6200","authenticated-orcid":false,"given":"Cosimo","family":"Cumbo","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Tota","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4382-9906","authenticated-orcid":false,"given":"Crescenzio Francesco","family":"Minervini","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Minervini","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Conserva","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Redavid","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Parciante","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Macchia","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Specchia","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-6594","authenticated-orcid":false,"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-6052","authenticated-orcid":false,"given":"Francesco","family":"Albano","sequence":"additional","affiliation":[{"name":"Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dremsek, P., Schwarz, T., Weil, B., Malashka, A., Laccone, F., and Neesen, J. (2021). Optical genome mapping in routine human genetic diagnostics\u2014Its advantages and limitations. Genes, 12.","DOI":"10.3390\/genes12121958"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sahajpal, N.S., Barseghyan, H., Kolhe, R., Hastie, A., and Chaubey, A. (2021). Optical genome mapping as a next-generation cytogenomic tool for detection of structural and copy number variations for prenatal genomic analyses. Genes, 12.","DOI":"10.1101\/2021.02.19.21251714"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ajhg.2021.06.001","article-title":"Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping","volume":"108","author":"Neveling","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.csbj.2020.07.018","article-title":"Advances in optical mapping for genomic research","volume":"18","author":"Yuan","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4939-8666-8_16","article-title":"Structural variation detection and analysis using bionano optical mapping","volume":"Volume 1833","author":"Chan","year":"2018","journal-title":"Methods in Molecular Biology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1936","DOI":"10.1002\/mgg3.1936","article-title":"Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics","volume":"10","author":"Dai","year":"2022","journal-title":"Mol. Genet. Genomic Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ajh.26587","article-title":"Optical genome mapping for structural variation analysis in hematologic malignancies","volume":"97","author":"Smith","year":"2022","journal-title":"Am. J. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-981-13-6037-4_7","article-title":"Bionano Genome Mapping: High-Throughput, Ultra-Long Molecule Genome Analysis System for Precision Genome Assembly and Haploid-Resolved Structural Variation Discovery","volume":"1129","author":"Bocklandt","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcp.1040910303","article-title":"Conditions controlling the proliferation of haemopoietic stem cells in vitro","volume":"91","author":"Dexter","year":"1977","journal-title":"J. Cell. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V68.3.790.790","article-title":"Stimulation of proliferation of human myeloid leukemia cells in culture: Applications for cytogenetic analysis","volume":"68","author":"Michaeli","year":"1986","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.hoc.2009.07.001","article-title":"Cytogenetics and molecular genetics of acute lymphoblastic leukemia","volume":"23","author":"Harper","year":"2009","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cancergencyto.2010.07.128","article-title":"Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: A CLL Research Consortium (CRC) Study","volume":"203","author":"Heerema","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/gcc.20691","article-title":"Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study","volume":"48","author":"Put","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/bloodadvances.2019001275","article-title":"Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma","volume":"4","author":"Mellors","year":"2020","journal-title":"Blood Adv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","article-title":"The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis","volume":"66","author":"Dewald","year":"1985","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"592087","DOI":"10.3389\/fimmu.2020.592087","article-title":"The Genome in a Three-Dimensional Context: Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer","volume":"11","author":"Rovirosa","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","article-title":"Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia","volume":"11","author":"Montefiori","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/2643-3230.BCD-20-0132","article-title":"Revealing the impact of structural variants in multiple myeloma","volume":"1","author":"Rustad","year":"2020","journal-title":"Blood Cancer Discov."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"a004077","DOI":"10.1101\/mcs.a004077","article-title":"Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH\/MYC and IGH\/BCL2 rearrangements","volume":"5","author":"Peterson","year":"2019","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41408-019-0255-z","article-title":"Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma","volume":"9","author":"Smadbeck","year":"2019","journal-title":"Blood Cancer J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cancergen.2020.02.008","article-title":"Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis","volume":"243","author":"Lopes","year":"2020","journal-title":"Cancer Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-21-0005","article-title":"The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma","volume":"27","author":"Sharma","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2010-07-295857","article-title":"Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies","volume":"117","author":"Tiu","year":"2011","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cancergen.2020.03.001","article-title":"Evidence-based review of genomic aberrations in B-lymphoblastic leukemia\/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia","volume":"243","author":"Akkari","year":"2020","journal-title":"Cancer Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cancergen.2018.07.004","article-title":"Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia","volume":"228\u2013229","author":"Chun","year":"2018","journal-title":"Cancer Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cancergen.2018.07.002","article-title":"Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders","volume":"228\u2013229","author":"Pugh","year":"2018","journal-title":"Cancer Genet."},{"key":"ref_28","first-page":"197","article-title":"Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic\/myeloproliferative and myeloproliferative neoplasms","volume":"228\u2013229","author":"Hodge","year":"2018","journal-title":"Cancer Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1182\/blood-2010-11-314393","article-title":"SNP array-based karyotyping: Differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes","volume":"117","author":"Afable","year":"2011","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/gcc.22112","article-title":"Single nucleotide polymorphism array karyotyping: A diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing","volume":"52","author":"Arenillas","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/17474086.2023.2193322","article-title":"Identifying prognostic gene panels in acute myeloid leukemia","volume":"16","author":"Serrano","year":"2023","journal-title":"Expert Rev. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41408-022-00718-1","article-title":"Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS\/AML patients","volume":"12","author":"Balducci","year":"2022","journal-title":"Blood Cancer J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcdb.2021.01.004","article-title":"Chromoanagenesis, the mechanisms of a genomic chaos","volume":"123","author":"Pellestor","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ccr.2013.04.025","article-title":"Chromoplexy: A New Category of Complex Rearrangements in the Cancer Genome","volume":"23","author":"Shen","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ostapi\u0144ska, K., Styka, B., and Lejman, M. (2022). Insight into the Molecular Basis Underlying Chromothripsis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063318"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","article-title":"High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.26487","article-title":"Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping","volume":"97","author":"Rack","year":"2022","journal-title":"Am. J. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"L\u00fchmann, J.L., Stelter, M., Wolter, M., Kater, J., Lentes, J., Bergmann, A.K., Schieck, M., G\u00f6hring, G., M\u00f6ricke, A., and Cario, G. (2021). The clinical utility of optical genome mapping for the assessment of genomic aberrations in acute lymphoblastic leukemia. Cancers, 13.","DOI":"10.3390\/cancers13174388"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/gcc.22971","article-title":"Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias","volume":"60","author":"Lestringant","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"s13742-015","DOI":"10.1186\/s13742-015-0044-y","article-title":"Optical mapping in plant comparative genomics","volume":"4","author":"Tang","year":"2015","journal-title":"GigaScience"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.ajhg.2021.05.012","article-title":"Optical genome mapping enables constitutional chromosomal aberration detection","volume":"108","author":"Mantere","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12935-022-02728-2","article-title":"Optical genome mapping identifies clinically relevant genomic rearrangements in prostate cancer biopsy sample","volume":"22","author":"Shim","year":"2022","journal-title":"Cancer Cel. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jmoldx.2022.09.009","article-title":"Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms","volume":"24","author":"Sahajpal","year":"2022","journal-title":"J. Mol. Diagn."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"106972","DOI":"10.1016\/j.leukres.2022.106972","article-title":"Whole-genome optical mapping to elucidate myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions","volume":"123","author":"Podvin","year":"2022","journal-title":"Leuk. Res."},{"key":"ref_48","unstructured":"Wing Chun Pang, A., Kosco, K., Sahajpal, N., Sridhar, A., Hauenstein, J., Clifford, B., Estabrook, J., Chitsazan, A., Sahoo, T., and Iqbal, A. (2022). Clinical Validation of Optical Genome Mapping for the Detection of Structural Variations in Hematological Malignancies. medRxiv."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/ijc.33942","article-title":"Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML\/MDS patients","volume":"150","author":"Gerding","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","article-title":"Optical Genome Mapping in Acute Myeloid Leukemia: A Multicenter Evaluation","volume":"7","author":"Levy","year":"2022","journal-title":"Blood Adv."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Suttorp, J., L\u00fchmann, J.L., Behrens, Y.L., G\u00f6hring, G., Steinemann, D., Reinhardt, D., von Neuhoff, N., and Schneider, M. (2022). Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia. Cancers, 14.","DOI":"10.3390\/cancers14092058"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood.2021014840","article-title":"CD34+CD19\u2212CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies","volume":"140","author":"Bueno","year":"2022","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/bloodadvances.2021006328","article-title":"Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping","volume":"6","author":"Jean","year":"2022","journal-title":"Blood Adv."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1097\/HS9.0000000000000700","article-title":"Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and during Treatment by Single-cell DNA Amplicon Sequencing","volume":"6","author":"Meyers","year":"2022","journal-title":"Hemasphere"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Puiggros, A., Ramos-Campoy, S., Kamaso, J., de la Rosa, M., Salido, M., Melero, C., Rodr\u00edguez-Rivera, M., Bougeon, S., Collado, R., and Gimeno, E. (2022). Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL). Cancers, 14.","DOI":"10.3390\/cancers14143376"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ramos-Campoy, S., Puiggros, A., Kamaso, J., Be\u00e0, S., Bougeon, S., Larr\u00e1yoz, M.J., Costa, D., Parker, H., Rigolin, G.M., and Blanco, M.L. (2022). TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype. Cancers, 14.","DOI":"10.3390\/cancers14153715"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1073\/pnas.1418577112","article-title":"Single-molecule analysis reveals widespread structural variation in multiple myeloma","volume":"112","author":"Gupta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"14671","DOI":"10.1038\/s41598-021-93835-z","article-title":"Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities","volume":"11","author":"Kriegova","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Estey","year":"2017","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood-2016-10-743765","article-title":"Near-haploid and low-hypodiploid acute lymphoblastic leukemia: Two distinct subtypes with consistently poor prognosis","volume":"129","author":"Safavi","year":"2017","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia","volume":"343","author":"Stilgenbauer","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2011-11-395269","article-title":"Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with \u2018normal\u2019 FISH: Correlations with clinicobiologic parameters","volume":"119","author":"Rigolin","year":"2012","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Gasc\u00f3n-y-mar\u00edn, I., Mu\u00f1oz-Novas, C., Rodr\u00edguez-Vicente, A.E., Quijada-\u00e1lamo, M., Hern\u00e1ndez-S\u00e1nchez, M., P\u00e9rez-Carretero, C., Ramos-Ascanio, V., and Hern\u00e1ndez-Rivas, J.\u00c1. (2021). From biomarkers to models in the changing landscape of chronic lymphocytic leukemia: Evolve or become extinct. Cancers, 13.","DOI":"10.3390\/cancers13081782"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: Definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2019.239947","article-title":"Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: A multi-center study","volume":"105","author":"Leeksma","year":"2020","journal-title":"Haematologica"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1080\/10428194.2016.1260126","article-title":"Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation","volume":"58","author":"Shah","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Aksenova, A.Y., Zhuk, A.S., Lada, A.G., Zotova, I.V., Stepchenkova, E.I., Kostroma, I.I., Gritsaev, S.V., and Pavlov, Y.I. (2021). Genome instability in multiple myeloma: Facts and factors. Cancers, 13.","DOI":"10.3390\/cancers13235949"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12185-022-03353-5","article-title":"Multiple myeloma with high-risk cytogenetics and its treatment approach","volume":"115","author":"Hanamura","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2021.04.014","article-title":"Chromothripsis as a pathogenic driver of multiple myeloma","volume":"123","author":"Maura","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-019-0660-0","article-title":"Extramedullary multiple myeloma","volume":"34","author":"Bhutani","year":"2020","journal-title":"Leukemia"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood.2021014309","article-title":"Guiding the global evolution of cytogenetic testing for hematologic malignancies","volume":"139","author":"Akkari","year":"2022","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/bjh.16360","article-title":"The power and potential of integrated diagnostics in acute myeloid leukaemia","volume":"188","author":"Haferlach","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1476-4598-9-120","article-title":"Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements","volume":"9","author":"Albano","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2018-02-832253","article-title":"Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease","volume":"132","author":"Branford","year":"2018","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.18.01468","article-title":"Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline","volume":"37","author":"Ismaila","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/11\/1841\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:41:24Z","timestamp":1760125284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/11\/1841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":83,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["diagnostics13111841"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13111841","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]}}}